U.S Physical Therapy Total Current Liabilities 2010-2024 | USPH

U.S Physical Therapy total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
U.S Physical Therapy Annual Total Current Liabilities
(Millions of US $)
2023 $102
2022 $85
2021 $83
2020 $93
2019 $61
2018 $42
2017 $40
2016 $25
2015 $19
2014 $26
2013 $23
2012 $16
2011 $16
2010 $14
2009 $15
U.S Physical Therapy Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $115
2024-06-30 $107
2024-03-31 $103
2023-12-31 $102
2023-09-30 $82
2023-06-30 $86
2023-03-31 $91
2022-12-31 $85
2022-09-30 $81
2022-06-30 $85
2022-03-31 $89
2021-12-31 $83
2021-09-30 $82
2021-06-30 $75
2021-03-31 $91
2020-12-31 $93
2020-09-30 $93
2020-06-30 $87
2020-03-31 $71
2019-12-31 $61
2019-09-30 $63
2019-06-30 $57
2019-03-31 $69
2018-12-31 $42
2018-09-30 $47
2018-06-30 $42
2018-03-31 $45
2017-12-31 $40
2017-09-30 $36
2017-06-30 $35
2017-03-31 $34
2016-12-31 $25
2016-09-30 $26
2016-06-30 $29
2016-03-31 $24
2015-12-31 $19
2015-09-30 $21
2015-06-30 $22
2015-03-31 $21
2014-12-31 $26
2014-09-30 $22
2014-06-30 $23
2014-03-31 $19
2013-12-31 $23
2013-09-30 $17
2013-06-30 $17
2013-03-31 $14
2012-12-31 $16
2012-09-30 $15
2012-06-30 $16
2012-03-31 $13
2011-12-31 $16
2011-09-30 $14
2011-06-30 $15
2011-03-31 $27
2010-12-31 $14
2010-09-30 $15
2010-06-30 $13
2010-03-31 $15
2009-12-31 $15
2009-09-30 $16
2009-06-30 $13
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.380B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00